Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5

Glycoconjugate vaccines based on isolated capsular polysaccharide (CPS) save millions of lives annually by preventing invasive pneumococcal disease caused by Streptococcus pneumoniae. Some components of the S. pneumoniae glycoconjugate vaccine Prevnar13 that contains CPS antigens from 13 serotypes u...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Proc Natl Acad Sci U S A
Autors principals: Lisboa, Marilda P., Khan, Naeem, Martin, Christopher, Xu, Fei-Fei, Reppe, Katrin, Geissner, Andreas, Govindan, Subramanian, Witzenrath, Martin, Pereira, Claney L., Seeberger, Peter H.
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2017
Matèries:
Physical Sciences
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5651752/
https://ncbi.nlm.nih.gov/pubmed/28973947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1706875114
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars